Cochrane Abstracts
Vigabatrin versus carbamazepine monotherapy for epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vigabatrin Versus Carbamazepine Monotherapy for Epilepsy." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434391/all/Vigabatrin_versus_carbamazepine_monotherapy_for_epilepsy. Accessed 08 November 2024.
Vigabatrin versus carbamazepine monotherapy for epilepsy. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434391/all/Vigabatrin_versus_carbamazepine_monotherapy_for_epilepsy. Accessed November 8, 2024.
Vigabatrin versus carbamazepine monotherapy for epilepsy. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434391/all/Vigabatrin_versus_carbamazepine_monotherapy_for_epilepsy
Vigabatrin Versus Carbamazepine Monotherapy for Epilepsy [Internet]. In: Cochrane Abstracts. [cited 2024 November 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434391/all/Vigabatrin_versus_carbamazepine_monotherapy_for_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vigabatrin versus carbamazepine monotherapy for epilepsy
ID - 434391
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434391/all/Vigabatrin_versus_carbamazepine_monotherapy_for_epilepsy
DB - Evidence Central
DP - Unbound Medicine
ER -
